These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29504258)

  • 1. Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin-angiotensin-aldosterone system.
    Aachmann-Andersen NJ; Christensen SJ; Lisbjerg K; Oturai P; Johansson PI; Holstein-Rathlou NH; Olsen NV
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans.
    Olsen NV; Aachmann-Andersen NJ; Oturai P; Munch-Andersen T; Bornø A; Hulston C; Holstein-Rathlou NH; Robach P; Lundby C
    J Physiol; 2011 Mar; 589(Pt 6):1273-81. PubMed ID: 20724370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system.
    Benck U; Haeckel S; Clorius JH; van der Woude FJ
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):58-67. PubMed ID: 17699388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems.
    Eggena P; Willsey P; Jamgotchian N; Truckenbrod L; Hu MS; Barrett JD; Eggena MP; Clegg K; Nakhoul F; Lee DB
    Am J Physiol; 1991 Nov; 261(5 Pt 1):E642-6. PubMed ID: 1951690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
    Sturrock ND; Lang CC; Coutie WJ; Struthers AD
    J Hypertens; 1995 Sep; 13(9):987-91. PubMed ID: 8586834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects.
    Nielsen CB; Pedersen EB
    J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study.
    Olsen NV; Olsen MH; Bonde J; Kanstrup IL; Plum I; Strandgaard S; Leyssac PP
    Br J Clin Pharmacol; 1997 May; 43(5):509-20. PubMed ID: 9159566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypoxaemia on water and sodium homeostatic hormones and renal function.
    Olsen NV
    Acta Anaesthesiol Scand Suppl; 1995; 107():165-70. PubMed ID: 8599271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
    Eiskjaer H; Sørensen SS; Danielsen H; Pedersen EB
    J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
    Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Visoná A; Lusiani L; Pagnan A
    Clin Pharmacol Ther; 1988 Aug; 44(2):211-6. PubMed ID: 2456174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.
    Rosenbaek JB; Al Therwani S; Jensen JM; Mose FH; Wandall-Frostholm C; Pedersen EB; Bech JN
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F378-F387. PubMed ID: 28490529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
    Skov J; Dejgaard A; Frøkiær J; Holst JJ; Jonassen T; Rittig S; Christiansen JS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E664-71. PubMed ID: 23463656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.